|
2024
|
Invention
|
Salts of avatrombopag. The invention relates to improved process to prepare avatrombopag hydrogen... |
|
|
Invention
|
Formulation comprising form b of avatrombopag maleate. The invention relates to tablet compositio... |
|
|
Invention
|
Solvates of trametinib. The present invention relates to solvates of compound of formula (1) and ... |
|
|
Invention
|
A process for making dabrafenib. The invention relates to a process for preparation of Dabrafenib... |
|
|
Invention
|
A process for making trametinib. The invention relates to a process for preparation of compound o... |
|
|
Invention
|
Process for preparing diroximel fumarate. Described is a process for preparing high purity diroxi... |
|
|
Invention
|
Crystalline forms of acalabrutinib hydrogen maleate. The invention relates to mixed ethanol water... |
|
|
Invention
|
A process for making osimertinib. The invention relates to a process for preparation of compounds... |
|
|
Invention
|
Pharmaceutical composition comprising enzalutamide.
The present invention relates to a tablet co... |
|
2023
|
Invention
|
Pharmaceutical composition comprising palbociclib. The present invention relates to a pharmaceuti... |
|
|
Invention
|
Pharmaceutical composition of siponimod. The present invention relates to pharmaceutical composit... |
|
|
Invention
|
Formulation comprising edoxaban and preparation thereof. The invention relates to the tablet comp... |
|
|
Invention
|
A process for preparation of cabozantinib or tivozanib. The presented invention relates to a proc... |
|
|
Invention
|
Stable formulation comprising obeticholic acid. The present invention relates to a stable pharmac... |
|
|
Invention
|
Crystalline form of asciminib hydrochloride. The application relates to the crystalline Form 1S o... |
|
|
Invention
|
Capillary gel electrophoresis separation of diastereomers of phosphorothioated oligonucleotides. ... |
|
|
Invention
|
Process for making palbociclib. The present invention relates to a process for preparation of pal... |
|
|
Invention
|
Prolonged release tofacitinib compositions without functional coating. The present invention rela... |
|
|
Invention
|
Budesonide two layers capsule formulation. The present invention relates to a Budesonide formulat... |
|
|
P/S
|
Pharmaceutical preparations, substances and compositions;
biological and biochemical drug and cu... |
|
|
Invention
|
Solid forms of copanlisib salts. The invention relates to solid forms of Copanlisib hydrogen phos... |
|
|
Invention
|
Solid forms of vismodegib. Presented invention relates to solid forms of Vismodegib, compound of ... |
|
|
Invention
|
Cabozantinib salt with l-(+)-tartaric acid and solid forms thereof.
The invention relates to sol... |
|
|
Invention
|
Cabozantinib salt with l-(+)-tartaric acid and solid forms thereof. The invention relates to soli... |
|
|
Invention
|
Solid forms of alectinib and alectinib salts.
The invention relates to Alectinib, compound of fo... |
|
|
Invention
|
Solid forms of alectinib and alectinib salts. The invention relates to Alectinib, compound of for... |
|
|
Invention
|
Improved process for preparation of copanlisib. The presented invention relates to a process for ... |
|
2022
|
Invention
|
Pharmaceutical composition comprising ibrutinib.
The present invention relates to a tablet compo... |
|
|
Invention
|
Pharmaceutical composition comprising ibrutinib. The present invention relates to a tablet compos... |
|
|
Invention
|
Pharmaceutical composition of bempedoic acid.
The presented invention relates to pharmaceutical ... |
|
|
Invention
|
Pharmaceutical composition of bempedoic acid. The presented invention relates to pharmaceutical c... |
|
|
Invention
|
A process for making osimertinib.
The invention deals with a novel process for preparation of th... |
|
|
Invention
|
A process for making osimertinib. The invention deals with a novel process for preparation of the... |
|
|
Invention
|
Crystalline forms of tafamidis nicotinamide adduct. The presented invention relates to Tafamidis ... |
|
|
Invention
|
Prolonged release tofacitinib compositions.
The present invention relates to a monolithic tablet... |
|
|
Invention
|
Prolonged release tofacitinib compositions. The present invention relates to a monolithic tablet ... |
|
|
Invention
|
Process for making melflufen or a salt thereof.
The present invention relates to process for pre... |
|
|
Invention
|
Process for making melflufen or a salt thereof. The present invention relates to process for prep... |
|
|
Invention
|
Lyophilized composition of copanlisib salt.
The presented invention relates to a lyophilized pha... |
|
|
Invention
|
Process for making ibrutinib.
The presented invention relates to a process for preparation of Ib... |
|
2021
|
P/S
|
Medical apparatus, namely, infusion and injection devices for administering drugs |
|
|
Invention
|
Siponimod salts and cocrystals.
The presented invention relates to solid forms of Siponimod adip... |
|
|
Invention
|
Improved process for preparation of apalutamide.
The presented invention relates to a process fo... |
|
|
Invention
|
Pharmaceutical composition comprising ibrutinib.
The present invention relates to a coated table... |
|
|
Invention
|
Crystalline form of ozanimod hydrochloride.
The presented invention relates to crystalline form,... |
|
2020
|
Invention
|
Crystalline forms of sodium salt of bempedoic acid.
The presented invention relates to crystalli... |
|
|
Invention
|
Pharmaceutical composition comprising eltrombopag bis(monoethanolamine).
The present invention r... |
|
|
Invention
|
Crystalline forms of bempedoic acid.
The presented invention relates to crystalline Form A and F... |
|
|
Invention
|
Controlled release tofacitinib compositions.
The present invention relates to a monolithic table... |
|
2019
|
P/S
|
Scientific analysis and testing services in the field of pharmaceuticals; pharmaceutical research... |
|
2017
|
P/S
|
TREATMENT OF MATERIALS FOR THE MANUFACTURE OF PHARMACEUTICAL AND BIOPHARMACEUTICAL PREPARATIONS; ... |
|
2015
|
P/S
|
Pharmaceutical preparations, substances and compositions; Biological and biochemical drug and Cul... |
|
|
P/S
|
Injection devices for medical purposes. |
|
|
P/S
|
injection devices for medical purposes. |
|
2014
|
P/S
|
Office functions relating to the registration of pharmaceutical preparations, namely compiling re... |
|
|
P/S
|
Office functions relating to the registration of
pharmaceutical preparations; compiling registra... |
|
|
P/S
|
Injection devices for medical purposes, namely, injections apparatus for the delivery of pharmace... |
|
|
P/S
|
Office functions relating to the registration of pharmaceutical preparations; Compiling registrat... |
|
2000
|
P/S
|
Pharmaceutical preparations for the treatment of alimentary tract and metabolism, blood and blood... |
|
|
P/S
|
Pharmaceutical preparations. |
